Carbetocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2

NCT03672045 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Postpartum Hemorrhage

Interventions

DRUG: Carbetocin

Sponsor

Samuel Lunenfeld Research Institute, Mount Sinai Hospital